Top compounds associated with response to PLCB4


Feature Type Standardized
Nominal ANOVA
mRNA Curcumin CTRPv2 pan-cancer AAC -0.12 0.002
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.002
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.002
mRNA Topotecan CCLE pan-cancer AAC -0.15 0.002
mRNA isoevodiamine CTRPv2 pan-cancer AAC -0.11 0.002
mRNA Erlotinib GDSC1000 pan-cancer AAC -0.19 0.002
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.11 0.003
mRNA MK 1775 CTRPv2 pan-cancer AAC -0.12 0.003
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.13 0.003
mRNA SNS-032 CTRPv2 pan-cancer AAC -0.12 0.003
Download CSV